CB2 Insights Announces Quarterly Revenue of $2.93 million for Q1 2020. EBITDA Nears Breakeven.

NEXT STORY
Adaptive Biotechnologies Announces Proposed Public Offering of Common Stock
PREV STORY
electroCore Provides Business Update and Select Financial Guidance
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Roche receives FDA approval for cobas HPV test for use on the cobas 6800/8800 Systems to identify women at risk for cervical cancer

author_avatar
NASDAQ Market News

Genelux Initiates Two Clinical Trials of GL-ONC1 in Ovarian Cancer and Solid Organ Cancers with Leading Oncology Institutions

First two patients dosed in Phase 1b Trial in Ovarian Cancer at Florida Hospital ...

author_avatar
NASDAQ Market News

Novavax Announces the Promotion of Dr. James F. Cummings to Vice President, Clinical Development and Translational Medicine

GAITHERSBURG, Md., May 11, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), today announced that ...

author_avatar
NASDAQ Market News